ICICI Prudential AMCs IPO entered its final day of bidding amid strong investor interest, supported by a firm grey market premium. Robust demand across investor categories, favourable brokerage recommendations and leadership in the asset management space underscore optimism, even as valuations remain on the higher side for short-term gains.
India's equity market is feeling the heat as the rupee hits record lows, raising concerns about the ongoing economic recovery. Foreign investors are pulling money out, impacting capital flows crucial for growth. While tech exporters benefit from a weaker rupee, other sectors face challenges, suggesting a period of selective investment and continued market volatility.
India's real estate sector experienced a strong breakout in 2025 with record residential sales and stabilizing commercial demand. Driven by end-user confidence and institutional participation, the market is poised for continued growth in 2026, with both luxury and mid-income housing segments expected to perform well.
In the Nifty500 pack, seven stocks' closing prices crossed above their 200 DMA (Daily Moving Averages) on December 15, 2025, according to stockedge.com's technical scan data. The 200-day daily moving average (DMA) is used by traders as a key indicator for determining the overall trend in a particular stock. As long as the stock is priced above the 200-day SMA on the daily timeframe, it is generally considered to be in an overall uptrend. Take a look:
KSH International plans to raise 420 crore via fresh equity for capacity expansion and debt repayment, alongside a 290 crore offer for sale. The company, a leading magnet winding wire manufacturer, is poised to benefit from EV market growth and infrastructure investments.
ICICI Prudential AMC's IPO is open for subscription, with Nimesh Shah expecting profitability pressures from growing AUM to be offset by falling unitholder fees. He highlighted operating profit growth as the key valuation metric for asset management businesses, which have historically required minimal capital for expansion.
India's primary market anticipates a significant influx of healthcare IPOs next year, with an estimated 20,000 crore in public issues expected. Major hospital chains like Manipal Hospitals and IVF platforms such as Indira IVF are preparing to list, driven by strong fundamentals and favorable valuations. This surge reflects the sector's growth momentum and attractive opportunities for raising capital.
